Skip to main content

Midazolam Injection Shortage

Last Updated: July 10, 2024
Status: Current

Products Affected - Description
    • Midazolam injection, Fresenius Kabi, 1 mg/mL, 10 mL vial, 10 count, NDC 63323-0411-10
    • Midazolam injection, Hikma, 1 mg/mL, 100 mL premixed bag, 10 count, NDC 00143-9380-10
    • Midazolam injection, Hikma, 1 mg/mL, 2 mL vial, 25 count, NDC 00641-6057-25
    • Midazolam injection, Hikma, 1 mg/mL, 5 mL vial, 10 count, NDC 00641-6059-10
    • Midazolam injection, Hikma, 1 mg/mL, 50 mL premixed bag, 10 count, NDC 00143-9379-10
    • Midazolam injection, Pfizer, 1 mg/mL, 10 mL vial, 10 count, NDC 00409-2587-05
Reason for the Shortage
    • Akorn ceased operations in February 2023.
    • Avet has midazolam injection available.
    • Fresenius Kabi has midazolam injection available.
    • Hikma did not provide a reason for the shortage.
    • Pfizer has midazolam injection on shortage due to manufacturing delays.
    • Sagent has midazolam injection available.
Available Products
    • Midazolam injection, Avet Pharmaceuticals, 1 mg/mL, 2 mL vial, 25 count, NDC 23155-0600-41
    • Midazolam injection, Avet Pharmaceuticals, 5 mg/mL, 10 mL vial, 10 count, NDC 23155-0601-42
    • Midazolam injection, Avet Pharmaceuticals, 5 mg/mL, 5 mL vial, 10 count, NDC 23155-0601-41
    • Midazolam injection, Fresenius Kabi, 1 mg/mL, 2 mL prefilled syringe, 24 count, NDC 76045-0001-20
    • Midazolam injection, Fresenius Kabi, 1 mg/mL, 2 mL vial, 25 count, NDC 63323-0411-12
    • Midazolam injection, Fresenius Kabi, 1 mg/mL, 5 mL vial, 25 count, NDC 63323-0411-25
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0002-10
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 1 mL fill in 2 mL vial, 25 count, NDC 63323-0412-25
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 10 mL vial, 10 count, NDC 63323-0412-10
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 2 mL vial, 25 count, NDC 63323-0412-02
    • Midazolam injection, Hikma, 1 mg/mL, 10 mL vial, 10 count, NDC 00641-6056-10
    • Midazolam injection, Hikma, 5 mg/mL, 1 mL vial, 25 count, NDC 00641-6061-25
    • Midazolam injection, Hikma, 5 mg/mL, 10 mL vial, 10 count, NDC 00641-6060-10
    • Midazolam injection, Hikma, 5 mg/mL, 2 mL vial, 25 count, NDC 00641-6063-25
    • Midazolam injection, Pfizer, 1 mg/mL, 2 mL preservative-free vial, 25 count, NDC 00409-2305-17
    • Midazolam injection, Pfizer, 1 mg/mL, 5 mL preservative-free vial, 10 count, NDC 00409-2305-05
    • Midazolam injection, Pfizer, 5 mg/mL, 1 mL preservative-free vial, 10 count, NDC 00409-2308-01
    • Midazolam injection, Pfizer, 5 mg/mL, 10 mL vial, 10 count, NDC 00409-2596-05
    • Midazolam injection, Pfizer, 5 mg/mL, 2 mL preservative-free vial, 10 count, NDC 00409-2308-02
    • Midazolam injection, Pfizer, 5 mg/mL, 5 mL vial, 10 count, NDC 00409-2596-03
    • Midazolam injection, Sagent, 1 mg/mL, 2 mL preservative-free vial, 10 count, NDC 25021-0655-02
    • Midazolam injection, Sagent, 5 mg/mL, 10 mL vial, 10 count, NDC 25021-0661-10
    • Midazolam injection, WG Critical Care, 1 mg/mL, 100 mL premixed bag, 10 count, NDC 44567-0611-10
    • Midazolam injection, WG Critical Care, 1 mg/mL, 50 mL premixed bag, 10 count, NDC 44567-0610-10

Estimated Resupply Dates

    • Fresenius Kabi has short-dated midazolam 1 mg/mL 10 mL vials available with an expiration date of < 8 months.
    • Hikma has midazolam 1 mg/mL 2 mL vials on allocation. The 1 mg/mL 5 mL vials are on back order and the company cannot estimate a release date. The 1 mg/mL 100 mL premixed bags are on back order and the company estimates a release date of late-July to early-August 2024. There are short-dated 1 mg/mL 50 mL premixed bags available with an expiration date of May 2025.
    • Pfizer has midazolam 1 mg/mL 10 mL vials on back order and the company estimates a release date of December 2024.

Updated

Updated July 10, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 25, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.